Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | May 04, 2023 | May 05, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date May 04, 2023 · Filed May 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,591 |
Reported balance
After 2023-05-04 transaction · row 1
1 source rowRow 1 · 2023-05-04 · Grant · Acquired 3,946 · Balance 73,591 F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2023 Filed May 5, 2023 20:27 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 3,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005469 · doc4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,591 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:08 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 4,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006632 · doc4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,645 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 06, 2021 Filed May 10, 2021 20:35 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 4,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-007880 · doc4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,768 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:47 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007408 · doc4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,005 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $185,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:25 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 4,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028926 · a4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,005 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $185,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 10, 2018 Filed May 11, 2018 22:29 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 6,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009201 · doc4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,015 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $185,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 09, 2017 Filed May 11, 2017 20:31 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 7,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009507 · doc4.xml · nonDerivative · entry 1 ROUX DAVID J · CIK 0001234273 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,906 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $185,000 divided by the closing price of common stock on the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.